Oct. 18, 2004 -- The drug CellCept works in controlling lupus symptoms, yet with few short-term side effects, research shows.
However, a new study shows it holds great promise in relieving lupus symptoms for the broader numbers of patients without kidney problems.
A group of researchers at the Mayo Clinic performed a six-month study involving 17 patients with lupus. At the study's end, 11 patients had a significant improvement in lupus symptoms, four had a partial improvement in lupus symptoms, and two had no improvement in lupus symptoms, reports lead researcher Kevin G. Moder, MD, a rheumatologist with the Mayo Clinic.
Those who responded with an improvement in lupus symptoms were also able to decrease their dose of prednisone, an immune-suppressing drug commonly used to treat lupus symptoms.
Moder presented his findings at the American College of Rheumatology Annual Scientific Meeting in San Antonio.
"This would be considered a nice addition to medications we can use for these patients -- an alternative and widely applicable to many patients," says Moder in a news release. "It's a significant step if the medication is effective but has fewer side effects" than current medications for lupus symptoms.